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During  the  course  of influenza A  virus  infection, two  different subsets  of 
cytotoxic T  lymphocytes (CTL) 1 are induced in mice and in humans. There are 
both subtype-specific CTL responses and responses that are crossreactive among 
the influenza A subtypes; both responses are restricted by class I major histocom- 
patibility complex (MHC) antigens (1-4). These CTL have been shown to play a 
crucial role in the recovery from influenza virus infection (5-8). 
The definition of the viral determinants that are recognized by these subsets 
of CTL is not complete (for review, see ref. 9).  Preparations of hemagglutinin 
(HA)  have  been  reported  (10,  11)  to  stimulate  a  subtype-specific  response. 
Wabuke-Bunoti and Fan (12) reported that the smaller subunit of HA (HA2), 
purified from bromelain-treated virions, induced a weak but significant second- 
ary CTL response, which was subtype-specific. Becht et al. (13), however, failed 
to  show  the  induction  of the  secondary CTL  response  using  purified  HA2 
obtained  by  the  selective  digestion  of virions  with  acid protease followed by 
treatment with mild detergent. On the other hand, several CTL clones appar- 
ently recognizing determinant(s) on the internal proteins, such as viral nucleo- 
protein (NP),  have been  isolated  (14).  Using a  panel  of recombinant viruses, 
Townsend and Skehel (14, 15) reported that the gene coding for NP determined 
the specificity of the effector lymphocytes, in that the target cells infected with 
the virus strain sharing only NP gene with the virus used for stimulation could 
be  lysed by  certain  clones  of CTL,  or  CTL  generated in  bulk  cultures and 
stimulated in special ways. For the recognition of the target cells by crossreactive 
CTL, in addition to viral HA (16,  17),  more conserved viral proteins, such as 
matrix protein and NP have been postulated to be responsible (9,  18,  19). 
To elucidate which viral  proteins are involved in  the recognition by MHC- 
restricted CTL, we examined the abilities of several influenza viral polypeptides 
prepared by gene cloning techniques to induce the secondary CTL responses. 
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Our results show that one of them (cl 3 protein), which is a hybrid protein of the 
first 81  amino acids of the viral NS 1 nonstructural protein and the HA2 subunit 
of viral HA, stimulated H-2-restricted, influenza virus subtype-specific secondary 
CTL in vitro. Furthermore, immunization of mice with cl 3 protein induced the 
generation of memory CTL response in vivo. 
Materials and  Methods 
Mice.  Male BALB/c mice were purchased from Charles River Breeding Laboratories, 
Inc. (Wilmington, MA), and used at the age of 4-5 wk. 
Virus.  Influenza A  viruses,  A/PR/8  (A/Puerto  Rico/8/34  [H1N1]),  A/BZ  (A/Bra- 
zil/ 11/78 [H 1N 1  ]), A/Chile (a/Chile/I/83  [H 1N 1  ]), A/JAP (A/Japan/305/57  [H2N2]), 
A/BK  (A/Bangkok/I/79  [H3N2]),  and  A/PC  (A/Port  Chalmers/1/73  [H3N2]),  were 
propagated in 9-d-old embryonated chicken eggs. Infected allantoic fluids were harvested 
on day 3 after infection and clarified by low-speed centrifugation. The supernatant fluid 
was divided into small vials and stored at -80°C until use. A/X31 (H3N2), a recombinant 
strain  obtained  by  cross  between  A/PR/8/34  and  A/Hong  Kong/1/68  (H3N2)  was 
generously provided by Dr. E. D. Kilbourne of the Mount Sinai School of Medicine, New 
York. 
Production  of lnfluenza  Virus-spec~c Proteins in E.  coli.  Influenza virus-specific poly- 
peptides were produced in E.  coli  using the expression system described previously (20- 
22).  Briefly, plasmids containing  DNA  fragments complementary to the  viral  RNA of 
A/PR/8 virus (23) were manipulated to achieve expression of the following products: (a) 
the NS1  nonstructural protein; (b) cl 3, the first 81 amino acids of NS1  fused to HA2; (c) 
A13, the first 81 amino acids of NS1  fused to the first 69 amino acids of HA2; (d) c7, the 
entire HA (minus the signal peptide); (e)  A7,  the HA1  and the first 69 amino acids of 
HA2; and (f) c36, the HA2 alone. The NS1 protein was purified as described previously 
(22).  Unlike  the  NS1  protein,  the  HA-containing  polypeptides  were  insoluble  when 
produced  in  E.  coli.  Therefore,  after  lysis  of  the  bacteria,  two  0.1%  deoxycholate 
extractions, and one 1% Triton X- 100 extraction to remove contaminating E. coli proteins, 
the HA-specific proteins were solubilized with 4 M urea (4°C for 30 rain). The urea was 
then removed by dialysis at 4°C. All proteins were stored in 50 mM Tris-I-ICl, pH 8.0,  1 
mM EDTA. The purity of these products was >80%. 
Immunization of Mice.  Mice were immunized with ~ 1,000 plaque forming units of the 
virus intranasally without anesthesia. To immunize mice with a polypeptide, the solution 
containing  500  #g/ml  of c13  protein  was  mixed  with  an  equal  amount  of complete 
Freund's adjuvant, and 0.2 ml of the mixture was inoculated into mice subcutaneously. 3 
wk after the primary injection, mice were given an intraperitoneal booster inoculation of 
50 ug without adjuvant. 
Induction  of Secondary  CTL  In  Vitro.  Spleens  were  aseptically  removed  from  mice 
immunized with the virus at least 3 wk before, and were teased through a stainless steel 
mesh. After lysing red blood cells by treatment with ACK lysing buffer (155 mM NH4C1, 
10 mM KHCO3, and 190 mM EDTA), cells were washed and resuspended in RPMI 1640 
medium containing 100 U/ml penicillin and  100 #g/ml streptomycin supplemented with 
10%  heat-inactivated fetal bovine serum at a  concentration  of 2.5-3.0  x  I0 6  cells/ml. 
Responder cells were cultured with virus-infected syngeneic spleen cells taken from normal 
mice at a ratio of 10:1,  or with various concentrations of peptides at 37°C for 5 d in 5% 
COy. 
CTL Assay.  P815  (H-2  d) cells were used as target cells for the standard  5~Cr-release 
assay. Single-cell suspensions of P815 cells were infected with the desired virus at an input 
multiplicity  of >10  PFU/cell.  Immediately after  inoculation  of the  virus,  250  #Ci  of 
Na,~5~CrO4 (New England Nuclear, Boston, MA) was added. After incubation at 37°C for 
90 rain, the target cells were washed twice with RPMI and further incubated at 37°C for 
6 h.  104 ~aCr-labeled target cells were incubated with effector cells at various ratios in a 
96-well, round-bottom microplate (Linbro, McLean, VA) at 37°C for 4 h. The supernatant 
fluid  (SNF)  of cultures  was  harvested  by the  aid  of harvesting  frames (Skatron  Inc., YAMADA ET  AL.  665 
Sterling, VA), and the radioactivities of SNF were counted in a gamma counter (Packard 
Instrument Co. Inc., Downers Grove, IL). Percent specific lysis was calculated as follows: 
percent  specific  lysis  =  (experimental  release  -  minimum  release)  ×  100/(maximum 
release -  minimum release). Maximum and minimum release were obtained by incubating 
target cells with  10%  Renex  30 solution (Ruger Chem. Co., Irvington, NJ) and medium 
alone, respectively. 
Maintenance of CTL in Presence of lnterleukin 2 (IL-2).  In vitro-stimulated spleen cell 
cultures were maintained  for 3  wk in RPMI  1640 containing  10%  FBS, 5  ×  10  -5 M  2- 
mercaptoethanol,  and  either  4%  rat  (Collaborative  Research  Inc.,  Lexington,  MA) or 
20% human (Meloy Laboratories Inc., Springfield, VA) IL-2. 
Determination of  Precursor Frequencies of CTL.  Precursor frequencies of influenza virus- 
specific CTL were determined by a limiting-dilution method (24). Spleen cell suspensions 
diluted to desired concentrations were distributed into round-bottom, 96-well microplates 
(100 #l/well), and cultured with 106 X-irradiated (2,500 rad) syngeneic spleen cells infected 
with A/PR/8 virus in the presence of exogenous IL-2. At least seven dilutions of the cell 
suspension were prepared, and 24 wells were seeded with each dilution. After incubation 
at  37°C  for  7  d,  each  well  was assayed for cytotoxicity against A/PR/8  virus-infected 
P815 target cells (2,000 cells/well) directly, or after splitting into two replicas.  Estimates 
of the  CTL  precursor  frequency were  calculated  by an  iterative  procedure  based  on 
maximum likelihood analysis described by Fazekas de St. Groth (25). 
Results 
Induction of Secondary CTL Response by Various Polypeptides.  We examined the 
ability of various polypeptides  to stimulate  A/PR/8  virus-immune  lymphocytes 
to generate a secondary CTL response in vitro. 2.5-3.0 ×  107 immune cells were 
cultured  with  various concentrations  of polypeptides  of A/PR/8  virus-infected 
syngeneic lymphocytes at  37°C for 5  d. Table  I  shows that immune spleen cells 
stimulated  with  A/PR/8  virus-infected  syngeneic cells were highly cytotoxic to 
A/PR/8  virus-infected  P815 cells but not to uninfected P815 cells, c 13 protein, 
which  is  a  hybrid  peptide  between  the  first  81  amino  acids  of NS1  and  HA2, 
stimulated  the secondary response  in vitro.  Although the level of killing by c 13 
TABLE  I 
Induction of Secondary CTL In Vitro by E. coli-derived  Protein 
Exp. 
Percent specific lysis 
Secondary  A/PR/8  Uninfected 
stimulation 
30  10  30  10 
A/PR/8*  62.5  40.5  6.7  2.6 
NS1  0.1  -3.2  4.3  0.0 
C13  19.3  4.0  0.5  -0.5 
A13  --2.5  --4.6  --1.3  0.0 
A7  2.1  --2.0  2.9  --0.9 
None  0.0  2.0  1.9  3.2 
A/PR/8  91.9  89.2  16.4  11.5 
c13  28.6  11.3  -1.2  -1.0 
c36  6.2  -2.5  -2.1  -1.1 
c7  4.4  -3.7  -0.8  -0.8 
Protein concentrations were 5/*g/ml and 12 #g/ml, in exp. 1 and 2, respectively. 
E:T (effector/target) ratios were 30:1 and 10:1. 
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protein-stimulated cells was lower than that obtained with effector cells induced 
by virus-infected stimulator cells, the induction of CTL response by c 13 protein 
was found to be dose-dependent, and the killing of virus-infected target cells was 
H-2-restricted  (not  shown).  Interestingly,  neither c36  protein,  which  is  HA2 
alone, nor c7 protein, which is the entire HA, induced any CTL responses. 
Virus Specificity  of Secondary  CTL Induced  by c13 Protein.  To determine the 
virus specificity of the secondary CTL induced by c13 protein, A/PR/8 virus- 
or A/PC virus-immune spleen cells were stimulated with cl 3 protein and tested 
for their ability to lyse both A/PR/8 virus- and A/PC virus-infected P815 cells. 
As shown in Table II, the effector cells stimulated by A/PR/8 virus- and A/PC 
virus-infected cells lysed both A/PR/8  virus- and A/PC virus-infected target 
cells,  c13  protein-induced effector cells,  however, lysed only A/PR/8  virus- 
infected target cells. We then tested cl 3 protein-induced effector cells for their 
cytotoxicity on  P815  cells infected with  other HI  and  H3  viruses.  Although 
these effector cells lysed all H 1 virus-infected target cells, regardless of the year 
of isolation, they did not iyse H3 virus-infected cells. Target cells infected with 
H2 viruses were not killed by cl 3 protein-induced effector cells (Fig.  1). These 
results  indicate  that  c13  protein  induced an  H1  virus  subtype-specific CTL 
response. To know whether internal proteins of A/PR/8 virus were involved in 
the recognition by c l 3 protein-induced CTL, their cytotoxicity against A/X31 
(H3N2) virus-infected target cells, which contain the internal proteins derived 
from  A/PR/8  virus  and  the  external  glycoproteins  from  H3N2  virus,  was 
examined. A/X31  virus-infected cells were not lysed by c13  protein-induced 
CTL, whereas they were lysed by A/PR/8  virus-induced CTL (Fig.  1 b).  This 
finding indicates that cl 3 protein-induced CTL recognize viral external glyco- 
proteins. 
Induction  of CTL Memory In  Vivo  by c13 Protein.  The observation  that  c13 
protein was able to stimulate influenza virus-specific secondary CTL response 
in vitro led us to investigate whether this protein has the potential to generate 
memory CTL response in vivo. Mice were immunized with 50 #g of cl 3 protein 
TABLE  II 
Virus Specificity of c l 3-induced CTL 
Stimulation  Percent specific lysis 
Primary  Secondary 
A/PR/8(H 1  N 1)  A/PC(H3N2)  Uninfected 
30  10  30  10  30  10 
A/PR/8  A/PR/8  80.5  59.4  72.8  55.8  4.2  0.2 
A/PC  77.9  76.1  74.2  59.3  2.3  2.1 
c13  33.2  14.8  -0.4  -0.7  1.7  1.3 
None  1.7  -0.8  0.5  -1.9  -0.9  -1.3 
A/PC  A/PR/8  96.0  72.9  74.3  57.5  9.8  1.8 
A/PC  92.3  75.6  85.1  80.0  10.2  3.8 
c13  6.7  1.0  4.3  -5.0  2.6  0.2 
None  -2.1  -1.1  -2.5  -3.5  1.2  -0.5 
A/PR/8 virus and A/PC virus were used in this experiment. Spleen cells taken from A/PR/8 virus- 
and A/PC virus-immune mice were stimulated with A/PR/8 virus-infected syngeneic spleen cells or 
with c13 protein (24/~g/ml), then assayed for cytotoxicity at E:T ratios of 30:1  and 10:1. 80 
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FIGURE  1.  Virus specificity of cl 3 protein-induced effector cells.  (a) Effector cells obtained 
by stimulation of A/PR/8 virus-immune spleen cells with A/PR/8 virus-infected cell (e) and 
those induced with c 13  protein (O) were tested for their cytotoxicity on P815 cells infected 
with A/PR/8 (H 1N 1), A/BZ (H 1N 1), and A/PC (H3N2) viruses. Normal spleen cells stimulated 
with A/PR/8 virus-infected cells (A), and those induced with cl 3 protein (A) were also tested 
along with immune (I) and normal (I-1) spleen cells cultured without stimulation. (b) A/PR/8 
virus-inamune spleen  cells stimulated  with  A/PR/8 virus-infected spleen cells (e) and  c13 
protein (O) were tested on P815 cells infected with A/PR/8 (H1N1), A/BZ (H1N1), A/Chile 
(H 1N 1), A/JAP (H2N2), and A/X31 (H3N2) viruses. 
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in complete Freund's adjuvant, and were boosted 3 wk later by the intraperito- 
neal  inoculation  of 50  /~g of c13  protein.  1  wk  after  the  secondary injection, 
spleen cells were obtained and cultured with A/PR/8  virus-infected stimulator 
cells at 37°C for 5 d. As shown in Table III, spleen cells taken from c13 protein- 
immunized  mice responded  to the  secondary stimulation  with  A/PR/8  virus- 
infected stimulator cells, resulting in the specific killing of A/PR/8 virus-infected 
P815  target  cells.  This  table  also  shows  that  these  effector cells  did  not  lyse 
A/PC virus-infected target cells, suggesting that the response was virus subtype- 
specific.  These effector cells failed to lyse A/PR/8  virus-infected L929  (H-2  k) 
cells (data not shown). 
Cytotoxicity  of Cultured  CTL  Derived from  In  Vitro  Stimulation  with  c13  Pro- 
tein.  We  tried  to  maintain  these  effector  cells  in  vitro  in  the  presence  of 
exogenous IL-2 after the secondary stimulation. The effector cells obtained by 
stimulation  of A/PR/8  virus-immune  cells  with  A/PR/8  virus-infected  cells 
showed a  high level of cytotoxicity to A/PR/8  and A/PC virus-infected target 
cells at lower E:T ratios after maintenance  for 3  wk  (Table IV).  c13  protein- 
stimulated A/PR/8 virus-immune cells lysed A/PR/8 virus-infected target cells 
more  efficiently than  A/PC  virus-infected  target  cells,  c13  protein-immune 
spleen  cells stimulated  with  A/PR/8  virus-infected cells killed A/PR/8  virus- 
infected target cells, but did not kill A/PC virus-infected target cells. These data 
indicate that c 13 protein-induced cytotoxicity was maintained in vitro for a long 
period in the presence of IL-2 without losing virus-specificity. 
Determination  of Precursor Frequency of CTL.  These results indicate that c13 
protein has an ability to induce not only secondary CTL activity in vitro but also 
memory CTL response in vivo. Therefore, we attempted to determine the CTL 
precursor  frequencies  of c13  protein-immune  mice.  1  wk  after  the  booster 
inoculation with c l 3  protein, spleen cells were tested for their CTL precursor 
frequencies by limiting-dilution analysis.  The results are contained in Table V. 
The frequencies of A/PR/8  virus- and  cl 3  protein-immune spleen cells were 
TABLE III 
Induction of Memory CTL in Mice Immunized with c13 Protein 
Stimulation  Percent specific  lysis 
Primary  Secondary 
A/PR/8  A/PC  Uninfected 
30  10  30  10  30  10 
A/PR/8  A/PR/8  68.7  37.7  55.7  30.8  -0.1  0.2 
None  6.8  1.7  4.5  -1.8  0.1  -0.6 
c13  A/PR/8  18.0  5.9  i0.8  -3.9  0.8  -1.4 
None  -1.5  i3.0  0.1  i5.3  -1.3  -1.2 
None  A/PR/8  3.3  2.1  -3.2  -3.5  -2.7  -2.2 
None  4.3  2.8  -2.1  -3,6  -2.0  i0.1 
BALB/c mice were immunized subcutaneously with 50 ~g of c13 protein emulsified in an equal 
volume of complete Freund's adjuvant and boosted intraperitoneally 3 wk later with 50 #g of c l 3 
protein without adjuvant. 1 wk after the booster injection, spleen cells were cultured with A/PR/8 
virus-infected syngeneic spleen cells  at 37°C for 5 d. CTL activity was assayed  on P815 cells infected 
with A/PR/8 virus and A/PC virus using E:T ratios of 30:1 and 10:1. YAMADA  ET  AL. 
TABLE  IV 
Cytotoxicity of CTL after Maintenance  In Vitro in Presence of lL-2 
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Stimulation  Percent specific lysis 
Primary  Secondary 
A/PR/8  A/PC  Uninfected 
10  3  10  3  10  3 
A/PR/8  A/PR/8  73.3  57.5  63.3  50.2  2.4  3.7 
c13  47.6  24.6  17.5  2.9  2.0  1.4 
c13  A/PR/8  26.6  7.2  6.4  -1.5  1.6  -0.6 
None  A/PR/8  -3.4  -4.8  -0.3  0.7  2.0  -0.4 
c13  0.8  -3.0  4.0  -2.1  0.1  -0.8 
Immunization of mice with the virus and cl 3 protein is given in the Materials and Methods. Protein 
concentration used for in vitro stimulation was 12.5 #g/ml. Cytotoxicity was assayed after 3 wk of in 
vitro culture, using E:T ratios of 10:1 and 3:1. 
TABLE  V 
Comparison of Precursor Frequencies 
hnmunization  Precursor fre-  Stimulation by:  95% confidence limit  with:  quencies (1/f) 
A/PR/8  A/PR/8  8,047  5,710-11,341 
c 13  A/PR/8  50,312  37,140-68,154 
None  A/PR/9  Nil 
A/PR/8  A/PR/8  15,111  11,004-20,752 
A/P R/8  c 13  73,177  49,482-108,219 
A/PR/8  None  Nil  -- 
Precursor frequencies of A/PR/8 virus- and c 13 protein-immunized mice were deter- 
mined by the limiting-dilution method (24). The estimates were calculated by solution 
of maximum likelihood equation, as described by Fazekas de St. Groth (25). 
estimated as one in 8,047 and 50,312, respectively. Spleen cells from nonimmune 
mice  did  not  contain  detectable  precursors.  Although  the  level  of precursor 
frequency of c13 protein-immune  spleen cells was lower than  that of A/PR/8 
virus-immune mice, these results showed that mice immunized with cl 3 protein 
had increased amounts of CTL precursors compared to nonimmune  mice.  We 
also determined  the  frequency  of CTL  precursors  in  A/PR/8  virus-immune 
spleen cells recognizing  c13 protein.  The frequency of A/PR/8  virus-immune 
spleen cells reacting with c 13 protein was estimated as  1/73,177,  whereas those 
reacting with A/PR/8 virus-infected cells were 1/15,111. To further define the 
virus specificity of c 13 protein-induced effector cells at the clonal level, we made 
two replicas from each plate of limiting-dilution  analysis and tested them against 
target cells infected with  H1  and  H3 virus strains.  As shown  in  Table VI,  the 
precursor frequencies of CTL reacting with A/PR/8  virus-infected stimulator 
cells were very close when  we tested  them  against  H1  and  H3  virus-infected 
target cells. However, the precursor frequency of CTL induced by c13 protein 
was strikingly  lower against  H3  virus-infected  targets  than  against  H1  virus- 
infected targets, indicating that virus specificity observed in bulk cultures (Table 670  CYTOTOXIC  T  CELL  RESPONSE  TO  BIOSYNTHETIC  PEPTIDE 
TABLE  VI 
Virus Specificity of c l 3 Protein-induced CTL at the Clonal Level 
Exp.  Stimulation 
1  PR8 
c13 
2  PR8 
c13 
3  c13 
4  c13 
Precursor frequency (l/f) 
H1NI  H3N2 
19,791  20,813 
14,477-27,057)*  (14,904-29,065) 
23,620  233,575 
17,679-31,560)  (146,644-372,040) 
21,256  25,813 
15,840-28,524)  (18,318-36,375) 
85,699  256,684 
59,164-124,228)  (137,692-478,506) 
63,047  290,846 
44,818-88,689)  (145,539-581,231 
114,501  Nil 
81,137-161,585) 
A/PR/8  virus-immune spleen  cells  were  cultured  in  limiting-dilution 
conditions with A/PR/8 virus-infected, syngeneic, X-irradiated spleen 
cells, or with c 13 protein (12.5 #g/ml) in the presence of X-irradiated, 
normal syngeneic spleen cells.  After 7 d  of incubation, the contents of 
each well were split into two aliquots, and their CTL activity was tested 
against both H 1 and H3 virus-infected target cells. The estimates were 
calculated as mentioned in the Materials and Methods. A/PR/8 (H 1N 1) 
and A/PC (H3N2) viruses were used to infect target cells in exp.  1 and 
2.  In exp.  3,  A/BZ (H1N1) and A/BK (H3N2)  viruses were  used.  In 
exp. 4, A/BZ and A/X31 virus were used as H1N1 and H3N2, respec- 
tively. 
* 95% confidence limit. 
II and Fig.  1)  reflected the recognition pattern of CTL precursors at a  clonal 
level. 
Discussion 
In this paper, we have shown that an influenza virus-specific hybrid protein, 
made of the first 81  amino acids of NS1  and the HA2 subunit of viral HA, and 
produced in E.  coli by recombinant DNA techniques, induced a secondary CTL 
response in vitro, and a memory CTL response in vivo. 
The observation that the entire HA, the HA2 alone, and the NS1  failed to 
induce the secondary CTL responses raised a question concerning which portion 
of the cl 3 protein, the NS1  and/or the HA2, contains the determinant respon- 
sible for inducing the CTL response.  To address this question, we tested the 
ability of cl 3 protein-induced effector cells to kill recombinant A/X31  (H3N2) 
virus-infected target cells,  because all of the  genome coding for the internal 
viral proteins of this virus was derived from the A/PR/8 parent virus, but the 
surface  glycoproteins  were  derived  from  the  parent  H3N2  virus  (26).  The 
observation that c13  protein-induced effector cells  were cytotoxic to A/PR/8 
virus-infected cells but not to A/X31  virus-infected target cells  (Fig.  1 b) indi- 
cates that c 13 protein-induced H 1 subtype-specific CTL recognize the antigenic 
difference expressed on the external glycoproteins. These results indicate that 
the HA2 portion of c l 3 protein has a determinant that is recognized by CTL 
precursors. YAMADA  ET  AL.  671 
It has been  reported  that  type A  influenza  virus-specific CTL generated  in 
bulk culture show a  broad specificity among type A  viruses (2),  while subtype- 
specific CTL have been also described (3,  10). The nature of the antigenic site(s) 
of the  virus recognized  by both subtype-specific and  crossreactive CTL  is  still 
unclear. Recently, Braciale et al. (27) reported that influenza virus HA expressed 
on  murine  cells,  using  DNA-mediated  gene  transfer,  was  recognized  by both 
subtype-specific CTL and a subset of crossreactive CTL. Although they did not 
show which subunit of HA was responsible for the recognition, it is conceivable 
that  the  important  determinant  for  the  subtype-specific recognition  could  be 
located on  the  HA2  subunit.  They also showed  that  some crossreactive CTL 
clones failed to lyse HA-expressing target cells, suggesting that  viral product(s) 
other than  HA might be recognized by crossreactive CTL.  Kees and Krammer 
(28) reported that most of their short term CTL clones were specific for internal 
viral components,  which appears to support this idea,  even though  the pattern 
of the  crossreactivity  was  different  from  that  of crossreactive  CTL  in  bulk 
cultures,  because  those  clones  crossreacted  among  the  viruses  sharing  genes 
coding for internal proteins. Furthermore, the isolation of CTL clones that react 
with  internal  proteins (14),  and  the observation that  mouse L cells transfected 
with viral NP gene can serve as target cells to crossreactive CTL (29) also seem 
to provide evidence that  the internal  protein(s) are involved in the recognition 
by influenza virus-specific crossreactive CTL. 
The frequency of CTL precursors reacting with the subtype-specific determi- 
nant  on  HA2  is generally  lower than  that  obtained  by stimulation  with  virus- 
infected cells, although  the CTL precursor frequencies varied between experi- 
ments. These results suggest that the majority of CTL precursors recognize viral 
determinant(s)  other than those on HA2. 
The  data  presented  in  Table  VI  show that  A/PR/8  virus-stimulated  clones 
lysed both A/PR/8 virus- and A/PC virus-infected target cells. These observa- 
tions are  different  from  those of Kees and  Krammer  (28),  who reported  that 
most CTL clones lysed only target  cells which were infected with a  virus that 
shared internal  proteins with the virus used for elicitation of the response. The 
reason  for  this  discrepancy  is  not  clear;  however,  since  they used  spleen  cells 
taken  from  mice  1  wk  after  the  primary  immunization,  when  the  primary 
response to infection was beginning  (1,  3),  it is conceivable that  the specificity 
pattern is different from that of spleen cells obtained from animals at least 3 wk 
after immunization.  On the contrary, our results are in accordance with those of 
Owen  et al.  (30),  who reported  that  ~80%  of A/PR/8  virus-stimulated  CTL 
clones  lysed  both  A/PR/8  (H1N1)  virus-  and  A/Northern  Territory/60/68 
(H3N2) virus-infected  cells.  As the  majority of CTL  clones reactive  with  c13 
protein lysed only target cells infected with H 1 subtype viruses, it seems unlikely 
that fully crossreactive CTL precursors recognize conserved antigenic portions 
of the  HA2  subunit.  These  results  support  the  concept that  highly conserved 
internal  proteins are recognized by these crossreactive CTL. 
Although we do not know the precise role of the first 81 amino acids of NS1, 
which is coupled to the HA2 in c13 protein,  this region  may be important  for 
maintaining  the tertiary structure of the protein, in order to present the immu- 
nodominant  site to the responding cells, or for serving as an adjuvant.  Since a 672  CYTOTOXIC  T  CELL  RESPONSE  TO  BIOSYNTHETIC  PEPT1DE 
derivative of cl 3 protein (A13 protein) lacking  153 amino acids of the carboxy 
terminal  end of the  HA2 did not stimulate a  CTL response,  the antigenic  site 
may be mapped  to this portion;  however, we could not rule out the possibility 
that the failure of A13 protein to induce CTL response may be due to the change 
of configuration because of the removal of this portion from c 13 protein. In this 
respect,  it  seems  worth  pointing  out  that  a  CNBr  cleavage  product  of HA2 
(between residues  103  and  123)  has  been  reported  (12)  to  induce  a  subtype- 
specific secondary CTL response.  The reason neither  the entire  HA nor HA2 
alone induced  a  CTL  response is not clear.  The  lack of glycosylation of these 
proteins may be an explanation,  although  it is also possible that special factor(s) 
may  be  required  for  the  generation  of CTL  response  by  these  proteins,  as 
described by Wabuke-Bunoti et al.  (31). 
In  conclusion,  we  have  shown  here  that  an  influenza  virus-specific  hybrid 
protein including the first 81  amino acids of NS1 and the HA2 subunit of viral 
HA, prepared  by recombinant  DNA techniques,  can produce both an in vitro 
secondary CTL response and in vivo generation of memory CTL in a subtype- 
specific manner.  Since  it  has  been  reported  (32)  that  a  subtype-specific CTL 
clone can  protect  mice  from  lethal  infection  with  influenza  A  virus,  it will  be 
interesting  to  see  whether  this  protein  induces  protective  immunity  to  the 
recipient mice. Experiments investigating this issue are now in progress. 
Summary 
We have  tested  the  abilities  of various  polypeptides of A/PR/8/34  (H1N1) 
virus, constructed by recombinant  DNA techniques, to induce influenza virus- 
specific secondary cytotoxic T  lymphocyte (CTL) responses.  A  hybrid protein 
(cl 3 protein), consisting of the first 81 amino acids of viral nonstructural protein 
(NS 1) and the HA2 subunit of viral hemagglutinin (HA), induced H-2-restricted, 
influenza virus subtype-specific secondary CTL in vitro, although other peptides 
did not.  Using a  recombinant  virus,  the viral determinant  responsible for rec- 
ognition was mapped to the HA2 portion of cl 3 protein.  Immunization  of mice 
with  c13  protein  induced  the  generation  of memory CTL  in  vivo.  The  CTL 
precursor frequencies of A/PR/8/34 virus- and cl 3 protein-immune mice were 
estimated as one in  8,047 and  50,312,  respectively. These results indicate  that 
c 13 protein primed recipient mice, even though the level of precursor frequency 
was below that observed in virus-immune mice. 
Received for publication  25 March 1985. 
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